Enter to open, tab to navigate, enter to select
Antitrust risk-shifting provisions in Teleflex Incorporated/Vascular Solutions, Inc. merger agreement
| December 01, 2016 • Antitrust Risk-shifting • $1 billion |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.